Metabolic syndrome, C-reactive protein and microalbuminuria in a rural Chinese population: A cross-sectional study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Jiang, Liping ^a   Huang, Wen ^a   Liang, Yuanbo ^a   Wang, Fenghua ^a   Duan, Xinrong ^a   Yang, Xiaohui ^a   Wen, Jiangping ^a   Wang, Ningli ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Epidemiology; Inflammation; Metabolic syndrome; Microalbuminuria

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD PRESSURE; CHINESE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; RISK ASSESSMENT; RURAL AREA; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CROSS-SECTIONAL STUDY; ETHNOLOGY; HEALTH SURVEY; METABOLISM; MIDDLE AGED; PROCEDURES; RURAL POPULATION;

ADULT; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POPULATION SURVEILLANCE; RURAL POPULATION;

EID: 84878365180     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-118     Document Type: Article

References (34)

1. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. Gerstein HC, Mann JF, Yi Q, JAMA 2001 286 421 426 10.1001/jama.286.4.421 11466120 (Pubitemid 32681484)
2. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. Pinto-Sietsma SJ, Janssen WM, Hillege HL, J Am Soc Nephrol 2000 11 1882 1888 11004219
3. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. Pedrinelli R, Dell'Omo G, Di Bello V, J Hum Hypertens 2002 16 79 89 10.1038/sj.jhh.1001316 11850764 (Pubitemid 34182916)
4. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Hillege HL, Fidler V, Diercks GF, Circulation 2002 106 1777 1782 10.1161/01.CIR.0000031732.78052.81 12356629
5. Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Solbu MD, Kronborg J, Jenssen TG, Atherosclerosis 2009 204 503 508 10.1016/j.atherosclerosis.2008.11.002 19091314
6. Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy. Palmer AJ, Roze S, Rodby RA, Dtsch Med Wochenschr 2006 131 1721 1726 10.1055/s-2006-947822 16868875 (Pubitemid 44532020)
7. Prevalence of the metabolic syndrome and overweight among adults in China. Gu D, Reynolds K, Wu X, Lancet 2005 365 1398 1405 10.1016/S0140-6736(05) 66375-1 15836888 (Pubitemid 40523734)
8. Association between microalbuminuria and the metabolic syndrome: NHANESIII. Palaniappan L, Carnethon M, Fortmann SP, Am J Hypertens 2003 16 952 958 10.1016/S0895-7061(03)01009-4 14573334 (Pubitemid 37315495)
9. The association between microalbuminuria and metabolic syndrome in the general population in Japan: the Takahata study. Hao Z, Konta T, Takasaki S, Inter Med 2007 46 341 346 10.2169/internalmedicine.46.6056 (Pubitemid 46585471)
10. Microalbuminuria and the metabolic syndrome and its components in the Chinese population. Lin CC, Liu CS, Li TC, Eur J Clin Invest 2007 37 783 790 10.1111/j.1365-2362.2007.01865.x 17888089 (Pubitemid 47480853)
11. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). Kshirsagar AV, Bomback AS, Bang H, Am J Cardiol 2008 101 401 406 10.1016/j.amjcard.2007.08.041 18237609 (Pubitemid 351175628)
12. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Nakamura M, Onoda T, Itai K, Intern Med 2004 43 919 925 10.2169/internalmedicine.43.919 15575240 (Pubitemid 39534794)
13. The relation of C-reactive protein to chronic kidney disease in African Americans:the Jackson Heart Study. Fox ER, Benjamin EJ, Sarpong DF, BMC Nephrol 2010 11 1 10.1186/1471-2369-11-1 20078870
14. Inflammation and microalbuminuria in nondiabetic and type 2diabetic subjects: The Insulin Resistance Atherosclerosis Study. Festa A, D'Agostino RD, Howard G, Kidney Int 2000 58 1703 1710 10.1046/j.1523-1755.2000.00331.x 11012904
15. Prevalence of chronic kidney disease in a rural Chinese adult population: the Handan Eye Study. Jiang L, Liang Y, Qiu B, Nephron Clin Pract 2010 114 295 302 10.1159/000276582
16. Prevalence and cause of low vision and blindness in a rural Chinese adult population: the handan eye study. Liang YB, Friedman DS, Wong TY, Ophthalmology 2008 115 1965 1972 10.1016/j.ophtha.2008.05.030 18684506
17. Recommendations on metabolic syndrome of Chinese Diabetes Society (Chinese). Expert Panel on Metabolic Syndrome of Chinese Diabetes Society, Chin J Diabetes 2004 12 156 161
18. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Grundy SM, Cleeman JI, Daniels SR, Circulation 2005 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
19. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Pearson TA, Mensah GA, Alexander RW, Circulation 2003 107 499 511 10.1161/01.CIR.0000052939.59093.45 12551878 (Pubitemid 36158056)
20. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Levey AS, Coresh J, Balk E, Ann Intern Med 2003 139 137 147 10.7326/0003-4819-139-2-200307150-00013 12859163
21. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Zhang L, Zuo L, Wang F, Mayo Clin Proc 2007 82 822 827 10.4065/82.7.822 17605962 (Pubitemid 47015461)
22. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Chen W, Chen W, Wang H, Nephrol Dial Transplant 2009 24 1205 1212 18952699
23. Relationship between the prevalence of microalbuminuria and components of metabolic syndrome in Shanghai. Li Q, Jia WP, Lu JQ, Clin J Epidemiol 2004 25 65 68
24. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Chen B, Yang D, Chen Y, Clin Chim Acta 2010 411 705 709 10.1016/j.cca.2010.01.038 20138167
25. Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease: A Dynamic and Life-Threatening Triad. Raimundo M, Lopes JA, Cardiol Res Pract 2011 2011 747 861
26. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Fröhlich M, Imhof A, Berg G, Diabetes Care 2000 23 1835 1839 10.2337/diacare.23.12.1835 11128362
27. Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III). Beddhu S, Kimmel PL, Ramkumar N, Cheung AK, Am J Kidney Dis 2005 46 577 586 10.1053/j.ajkd.2005.06.014 16183411 (Pubitemid 41383935)
28. Distributions of C-reactive protein and its association with metabolic syndrome in middle aged and older Chinese people. Ye X, Yu Z, Li H, J Am Coll Cardiol 2007 49 1798 1805 10.1016/j.jacc.2007.01.065 17466231 (Pubitemid 46629126)
29. Association of C-reactive protein and metabolic syndrome in a rural Chinese population. Wen J, Liang Y, Wang F, Clin Biochem 2009 42 976 983 10.1016/j.clinbiochem.2009.03.026 19358836
30. C-reactive protein and microalbuminuria in a multi- ethnic Asian population. Sabanayagam C, Lee J, Shankar A, Nephrol Dial Transplant 2010 25 1167 1172 10.1093/ndt/gfp591 19914996
31. Increased risk of chronic kidney disease in elderly with metabolic syndrome and high levels of C-reactive protein: Kahrizak Elderly Study. Fakhrzadeh H, Ghaderpanahi M, Sharifi F, Kidney Blood Press Res 2009 32 457 463 10.1159/000274046 20068351
32. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults. Lee JE, Choi SY, Huh W, Am J Hypertens 2007 20 1189 1194 17954366 (Pubitemid 47588810)
33. Effect of statin therapy on C-reactive protein levels: the Pravastatin Inflammation / CRP Evaluation (PRINCE): a randomized trial and cohort study. Albert MA, Danielson E, Rifai N, Ridker PM, PRINCE Investigators, JAMA 2001 286 64 70 10.1001/jama.286.1.64 11434828 (Pubitemid 32606333)
34. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. Nissen SE, Tuzcu EM, Schoenhagen P, N Engl J Med 2005 352 29 38 10.1056/NEJMoa042000 15635110 (Pubitemid 40075678)